IPSEN (IPN.PA) Stock Fundamental Analysis
Europe - EPA:IPN - FR0010259150 - Common Stock
121.3 EUR
+1.8 (+1.51%)
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 52 industry peers in the Pharmaceuticals industry. While IPN has a great health rating, its profitability is only average at the moment. IPN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IPN had positive earnings in the past year.
In the past year IPN had a positive cash flow from operations.
In the past 5 years IPN has always been profitable.
IPN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.56%, IPN is in line with its industry, outperforming 57.69% of the companies in the same industry.
The Return On Equity of IPN (10.59%) is comparable to the rest of the industry.
IPN has a better Return On Invested Capital (14.88%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IPN is below the industry average of 15.23%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
Looking at the Profit Margin, with a value of 11.91%, IPN is in line with its industry, outperforming 53.85% of the companies in the same industry.
In the last couple of years the Profit Margin of IPN has declined.
With a decent Operating Margin value of 26.01%, IPN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
IPN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 83.32%, IPN belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPN is creating value.
The number of shares outstanding for IPN has been increased compared to 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for IPN has been reduced compared to a year ago.
2.2 Solvency
IPN has an Altman-Z score of 4.44. This indicates that IPN is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.44, IPN is doing good in the industry, outperforming 65.38% of the companies in the same industry.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
IPN has a Debt to FCF ratio of 1.69. This is amongst the best in the industry. IPN outperforms 88.46% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
IPN has a Debt to Equity ratio of 0.20. This is in the better half of the industry: IPN outperforms 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.44 |
ROIC/WACC1.89
WACC7.86%
2.3 Liquidity
A Current Ratio of 1.98 indicates that IPN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.98, IPN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
IPN has a Quick Ratio of 1.80. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Quick ratio of 1.80. This is amongst the best in the industry. IPN outperforms 82.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
Measured over the past years, IPN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.79% on average per year.
Looking at the last year, IPN shows a quite strong growth in Revenue. The Revenue has grown by 9.45% in the last year.
Measured over the past years, IPN shows a small growth in Revenue. The Revenue has been growing by 5.83% on average per year.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 6.15% on average per year.
IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y5.2%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPS Next 5Y6.15%
Revenue Next Year7.07%
Revenue Next 2Y5.88%
Revenue Next 3Y6.24%
Revenue Next 5Y5.61%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 11.81 indicates a reasonable valuation of IPN.
Compared to the rest of the industry, the Price/Earnings ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 82.69% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.00, IPN is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.81, the valuation of IPN can be described as reasonable.
Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 76.92% of the companies are valued more expensively.
IPN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.81 | ||
| Fwd PE | 10.81 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 96.15% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IPN is valued a bit cheaper than 63.46% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.71 | ||
| EV/EBITDA | 5.63 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IPN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)2.27
PEG (5Y)1.34
EPS Next 2Y4.52%
EPS Next 3Y5.82%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.16%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.98, IPN has a dividend in line with its industry peers.
With a Dividend Yield of 1.16, IPN pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
25.90% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPA:IPN (10/29/2025, 5:29:31 PM)
121.3
+1.8 (+1.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners15.12%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap10.17B
Revenue(TTM)3.76B
Net Income(TTM)447.90M
Analysts70
Price Target130.09 (7.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.16% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.22%
PT rev (3m)0.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)3.35%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.32%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.81 | ||
| Fwd PE | 10.81 | ||
| P/S | 2.7 | ||
| P/FCF | 19.71 | ||
| P/OCF | 11.33 | ||
| P/B | 2.4 | ||
| P/tB | 7.61 | ||
| EV/EBITDA | 5.63 |
EPS(TTM)10.27
EY8.47%
EPS(NY)11.22
Fwd EY9.25%
FCF(TTM)6.15
FCFY5.07%
OCF(TTM)10.71
OCFY8.83%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)2.27
PEG (5Y)1.34
Graham Number107.98
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexgc growth 3Y-59.92%
ROICexgc growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.44 |
F-Score7
WACC7.86%
ROIC/WACC1.89
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y5.2%
EPS Next 2Y4.52%
EPS Next 3Y5.82%
EPS Next 5Y6.15%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year7.07%
Revenue Next 2Y5.88%
Revenue Next 3Y6.24%
Revenue Next 5Y5.61%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year32.82%
EBIT Next 3Y13.53%
EBIT Next 5Y8.05%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%
IPSEN / IPN.PA FAQ
What is the fundamental rating for IPN stock?
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
Can you provide the valuation status for IPSEN?
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
Can you provide the profitability details for IPSEN?
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
What is the earnings growth outlook for IPSEN?
The Earnings per Share (EPS) of IPSEN (IPN.PA) is expected to grow by 5.2% in the next year.
Can you provide the dividend sustainability for IPN stock?
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.9%.